| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051615656 |
| P356 | DOI | 10.1007/S00774-009-0127-X |
| P698 | PubMed publication ID | 19866334 |
| P2093 | author name string | Shigeyuki Wakitani | |
| Hiroaki Nakamura | |||
| Yoshifumi Naka | |||
| Kunio Takaoka | |||
| Yuuki Imai | |||
| Yoshitaka Eguchi | |||
| Yuusuke Hashimoto | |||
| P2860 | cites work | Novel regulators of bone formation: molecular clones and activities | Q24297338 |
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| RANK-L and RANK: T cells, bone loss, and mammalian evolution | Q28203468 | ||
| Bone: formation by autoinduction | Q28251545 | ||
| Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
| Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist | Q33219810 | ||
| Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). | Q33226192 | ||
| The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? | Q34440020 | ||
| Clinical evaluation of recombinant human bone morphogenetic protein-2. | Q34591409 | ||
| Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts | Q34679499 | ||
| Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration | Q36638028 | ||
| Transplantation of skin fibroblasts expressing BMP-2 contributes to the healing of critical-sized bone defects | Q36691555 | ||
| Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. | Q37109228 | ||
| Effect of bone morphogenetic protein-6 on macrophages | Q39887647 | ||
| Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway | Q40007470 | ||
| Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. | Q40271346 | ||
| Joint erosions and patients with early rheumatoid arthritis | Q40931437 | ||
| Blocking of tumor necrosis factor activity promotes natural repair of osteochondral defects in rabbit knee | Q42004548 | ||
| Treatment of open fractures of the shaft of the tibia | Q42644772 | ||
| Interleukin-1β enhance and tumor necrosis factor-α inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells | Q42799198 | ||
| Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats | Q44211613 | ||
| A biodegradable polymer as a cytokine delivery system for inducing bone formation. | Q45972847 | ||
| Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant | Q46405813 | ||
| A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: A potential treatment for infected bone defects | Q46945560 | ||
| RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. | Q51032592 | ||
| Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing. | Q51811482 | ||
| Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. | Q52100443 | ||
| Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. | Q53787487 | ||
| Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists | Q56864876 | ||
| Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis | Q57779892 | ||
| T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 | ||
| Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists | Q70466614 | ||
| A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis | Q73235899 | ||
| Tumor necrosis factor inhibitors for rheumatoid arthritis | Q80129386 | ||
| Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis | Q80695386 | ||
| Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model | Q81375837 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 157-164 | |
| P577 | publication date | 2009-10-29 | |
| P1433 | published in | Journal of Bone and Mineral Metabolism | Q15767236 |
| P1476 | title | Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation | |
| P478 | volume | 28 |
| Q38010645 | Altered bone biology in psoriatic arthritis |
| Q37313318 | Bone formation induced by BMP-2 in human osteosarcoma cells |
| Q27013942 | Brief review of models of ectopic bone formation |
| Q30376710 | Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering. |
| Q39832508 | Different effects of indomethacin on healing of shaft and metaphyseal fractures |
| Q34920114 | Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice |
| Q36013662 | Etanercept does not impair healing in rat models of tendon or metaphyseal bone injury |
| Q35129179 | Inflammation and uncoupling as mechanisms of periodontal bone loss |
| Q36106613 | Studies of bone morphogenetic protein-based surgical repair |
| Q50169538 | The Bone Building Blues: Self-hardening copper-doped calcium phosphate cement and its in vitro assessment against mammalian cells and bacteria |
| Q98288395 | The Influence of Adalimumab and Cyclosporine A on the Expression Profile of the Genes Related to TGFβ Signaling Pathways in Keratinocyte Cells Treated with Lipopolysaccharide A |
| Q39142580 | The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling |
| Q35546476 | The role of PGRN in musculoskeletal development and disease |
| Q30368848 | When 1+1>2: Nanostructured composites for hard tissue engineering applications |
Search more.